About
Basic Data Updated:
16 days agoThe trading of pharmaceutical and wellness products is the main focus of Glaxosmithkline Consumer Private Limited. This company, which is a Joint Venture between GlaxoSmithKline plc and Novartis AG, was established with the purpose of manufacturing and/or packaging various items. These items include pharmaceuticals, medicinal products, generics, bulk drugs, over the counter medicines, analgesics, vitamins, and tonics of all kinds. The company holds the rights to use and market these products under its own brand names and trademarks. Additionally, GCPL is also involved in research, development, and testing programs, as well as distribution and other dealings related to these items. Furthermore, the company provides diagnostic, chemical, and drug analysis services, as well as physician supp... Read More
Industry
Company Details
- Location
Patiala, Punjab, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
CIN/LLPIN/FCRN | U24232PB2014FTC039082 |
Company No. | 039082 |
Company Classification | Private Limited Foreign Company Incorporated In India |
Incorporation Date | 04 Dec 2014 |
Date of AGM | 30 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Chandigarh |
Financials of Glaxosmithkline Consumer Private Limited
Glaxosmithkline Consumer Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 9.07% decrease. The company also saw a slight improvement in profitability, with a 0.36% increase in profit. The company's net worth dipped by a decrease of 9.62%.
Enhance accessibility to Glaxosmithkline Consumer's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Glaxosmithkline Consumer's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Glaxosmithkline Consumer Private Limited
Unlock and access historical data on people associated with Glaxosmithkline Consumer, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
MS
Meenu Singhal Company SecretaryAppointment Date: 16-Jan-2024
Status: Current
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Director Appointment
Meenu Singhal was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jan 2024 & has been associated with this company since 3 months 20 days .
16 Jan 2024Annual General Meeting
Glaxosmithkline Consumer Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Glaxosmithkline Consumer Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
31 Mar 2023Director Appointment
Raj Kumar Khemani was appointed as a Director was appointed as a Director on 22 Jul 2022 & has been associated with this company since 1 year 9 months .
22 Jul 2022Director Appointment
Rupendra Yadav was appointed as a Nominee Director was appointed as a Nominee Director on 16 Jun 2021 & has been associated with this company since 2 years 10 months .
16 Jun 2021
Recent News, Updates & Announcement
- Peoples Bank KS Invests 431000 in GSK plc NYSEGSK.
Etfdailynews 12 Jan 2024
- GSK8217s Nucala for severe eosinophilic asthma gains approval in China.
Pharmaceutical Technology 11 Jan 2024
- GSK strong finish expected says Barclays.
Proactive 09 Jan 2024
- GSKs Licensing Agreement with Hansoh Pharma for HS20093.
Global Legal Chronicle 09 Jan 2024
- GSK plc NYSEGSK Shares Acquired by Horizon Bancorp Inc IN.
Etfdailynews 02 Jan 2024
Frequently asked questions
What is the Incorporation or founding date of Glaxosmithkline Consumer Private Limited?